Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners.
D000818:Animals; D000956:Antigens, Viral; D002051:Burkitt Lymphoma / Q000235:genetics* / Q000382:microbiology; D002277:Carcinoma / Q000235:genetics* / Q000382:microbiology; D002459:Cell Fusion; D002462:Cell Membrane / Q000648:ultrastructure; D002472:Cell Transformation, Viral; D002875:Chromosomes; D002903:Chromosomes, Human, 19-20; D002904:Chromosomes, Human, 21-22 and Y; D005347:Fibroblasts / Q000166:cytology; D005814:Genes, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics* / Q000276:immunology; D006801:Humans; D006822:Hybrid Cells / Q000382:microbiology*; D007065:Idoxuridine / Q000494:pharmacology; D008214:Lymphocytes / Q000166:cytology; D051379:Mice; D009303:Nasopharyngeal Neoplasms / Q000235:genetics* / Q000382:microbiology
D000956:Antigens, Viral; D007065:Idoxuridine